Ambrosia launches revolutionary “Direct-to-Apple Watch” NightRider BluCon for Continuous Glucose Monitoring

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN FRANCISCO, July 19, 2019 /PRNewswire/ — Ambrosia Systems, a fast growing medical  technology company, today announced the launch of the next version of NightRider BluCon. The new NightRider BluCon works with Apple watch to display glucose readings from the FreeStyle Libre and Libre Pro sensors on Apple watch without the phone. This will help parents of the millions of Type 1 diabetic children monitor their children’s glucose levels when the child is away. Currently, parents don’t have a way to know the current glucose levels of their Type 1 diabetic child if he or she is not carrying their phone, which most schools don’t allow. Also, it is difficult for young children to carry their phone all the time.

After the initial setup of Ambrosia’s NightRider and LinkBluCon app on the iPhone, the user can change the mode to Apple Watch on LinkBluCon’s settings screen, this will switch the NightRider connection from the iPhone to Apple Watch and will start displaying glucose readings on Apple Watch without the phone. If Apple Watch has a cellular connection, parents can install Ambrosia’s FollowBluCon app on their phone and, after setup, will be able to see glucose readings updates of their child every five minutes.

Disclaimer:

Ambrosia apps are not FDA approved and should not be used to make medical decisions.
FreeStyle Libre is a trademark of Abbott Diabetes Care Inc. Ambrosia Systems Inc. does not have any kind of relationship with Abbott Diabetic Care or Abbott Laboratories.

About Ambrosia Systems

Ambrosia Systems is a fast growing medical technology company focused on building easy to use and affordable technology solutions for patients, providers, payers and caregivers. The NightRider BluCon is currently in use in more than 100 countries with FreeStyle Libre, FreeStyle Libre 2 and FreeStyle Libre Pro sensors. To learn more, visit www.ambrosiasys.com

Media Contacts: Mia Flaherty, Ambrosia Systems Inc. mia.flaherty@ambrosiasys.com, +1-415-293-8242

View original content to download multimedia:http://www.prnewswire.com/news-releases/ambrosia-launches-revolutionary-direct-to-apple-watch-nightrider-blucon-for-continuous-glucose-monitoring-300887904.html

SOURCE Ambrosia Systems

Staff

Recent Posts

Mobile-health Network Solutions Announces H1 FY2025 Results; Continues on Drive Towards Scale and Profitability

Singapore, Singapore--(Newsfile Corp. - June 16, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or…

60 minutes ago

Sightview Names Tycene Fritcher as CEO

Eyecare technology company will implement new branding, appoint key executives in organizational refreshDURHAM, N.C.--(BUSINESS WIRE)--#EHR--Sightview,…

6 hours ago

Ash and Impilo Partner to Deliver Seamless At-Home Health Monitoring and Testing Nationwide

NEW YORK--(BUSINESS WIRE)--Ash, a leading at-home health testing platform, and Impilo, a leader in enabling…

6 hours ago

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial…

6 hours ago

Barton Associates’ Dan Bassani Named to SIA’s 2025 “40 Under 40” List

Sales leader honored for driving AI transformation and accelerating growth across the organization PEABODY, Mass.,…

6 hours ago

The Harbor Dental Society Partners with Torch Dental to Bring Efficiency and Cost Savings to Member Dentists

NEW YORK, June 16, 2025 /PRNewswire/ -- Torch Dental, a leading platform specializing in dental…

6 hours ago